BTIG raised the firm’s price target on Akebia (AKBA) to $10 from $5 and keeps a Buy rating on the shares. The firm cites the company’s Vafseo ...

Prologis (NYSE:PLD – Get Free Report) had its price objective cut by analysts at BTIG Research from $154.00 to $134.00 in a report released on Friday. The brokerage currently has a “buy” rating on the ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.65% of ...

Beyond Air Inc (XAIR) stock saw a modest uptick, ending the day at $0.42 which represents a slight increase of $0.05 or 13.51% from the prior close of $0.37. The stock opened at $0.4 and touched a low ...

Intuitive Surgical (NASDAQ:ISRG) shares maintained their Buy rating and a $561.00 price target from BTIG, despite potential ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

Fiverr International Ltd. (NYSE:FVRR – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten ...

BTIG analyst Thomas Shrader maintained a Buy rating on Alector (ALEC – Research Report) yesterday and set a price target of $5.00. The ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target. According to ...

to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology names. BTIG is increasing its estimates for U.S ...

BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating on the shares as part of a broader research note updating the firm ...